To study the possibility to revert the E- to N-cadherin switch and the tumor phenotype in metastatic melanoma, the appropriate cellular model (i.e. aggressive metastasis-derived melanoma cells that do not express E-cadherin but strongly express N-cadherin) was first selected. This evidence concerns the gene CDH1 and melanoma.